PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2013
CASE
AUTH/2603/5/13 Roche Products ⭐ Case of the Week

Roche: hotel bar drinks and dinner around BSH meeting logistics discussion found disproportionate (AUTH/2603/5/13)

Anonymous complaint about Roche buying drinks in a hotel bar during BSH 2013. Panel found one instance (Sunday pre-conference bar drinks plus…

2013
CASE
AUTH/2583/3/13 Leo Pharma

Leo Pharma Picato BMJ ad: β€œrevolutionary”/β€œshortest duration” claim and imagery found misleading (AUTH/2583/3/13)

A Picato journal ad using β€œThe revolutionary, shortest duration…” plus a high-speed train implied broader indication and faster effect. PMCPA found breaches…

2013
CASE
AUTH/2637/9/13 Sanofi

Sanofi Lyxumia β€œSpeaker Club” invite: unclear email created impression of Β£1,000 for attending a promotional meeting (AUTH/2637/9/13)

Sanofi invited HCPs to a Lyxumia Speaker Club and referenced Β£1,000 payment. Panel found no inducement/payment breach on the narrow allegation, but…

2013
CASE
AUTH/2606/5/13 Takeda

AUTH/2606/5/13: General Practitioner v Takeda β€” Prostap meeting Q&A (no breach)

A GP alleged a Takeda-sponsored meeting speaker said Prostap injection route β€œdid not matter”, implying off-licence promotion. Panel found evidence insufficient on…

2012
CASE
Flynn Pharma

Flynn Pharma: Circadin ad claim β€˜Current guidance states…’ ruled misleading (Clause 7.2)

A Circadin journal ad said β€œCurrent guidance states…” but the source was a BAP consensus statement, not NICE/AWMSG. The Panel found the…

2013
CASE
AUTH/2640/9/13 ⭐ Case of the Week

Anonymous v Nicoventures (AUTH/2640/9/13): Call rates set pre-licence for advance notification – no breach

MHRA referred a complaint that Nicoventures set pre-licence call rates for HDMs ahead of Voke’s authorisation. Panel found advance budget notification was…

2016
CASE
AUTH/2821/2/16 Sanofi

Sanofi Genzyme: patient organisation guests at BIA gala dinners ruled inappropriate hospitality (AUTH/2821/2/16)

Sanofi Genzyme admitted inviting patient organisation members to BIA gala dinners (2014/2015) with significant hospitality and likely >Β£75 subsistence, without clear educational…

2015
CASE
Bayer

Bayer breach over Xarelto leavepiece: NOAC comparison table and claim implied head-to-head evidence

PMCPA ruled Bayer’s Xarelto leavepiece misleading: a table and prominent claim implied direct comparisons vs other NOACs despite no head-to-head trials. Breaches…

2015
CASE
AUTH/2754/5/15 Merck Serono

Merck Serono breach over MS nurse call frequency driven by 6-contacts/day target (AUTH/2754/5/15)

Anonymous MS nurse complained of frequent, often unbooked rep visits and multiple attendees. Panel found a 6-contacts/day target lacked clear guidance and…

2014
CASE
AUTH/2736/9/14 Sanofi

Sanofi voluntary admission: systemic failures in patient organisation agreements and disclosure (AUTH/2736/9/14)

Sanofi self-reported widespread failures to have certified written agreements and to accurately/timely disclose support to patient organisations (2013–2014), plus non-disclosure of sponsorship…

2014
CASE
AUTH/2725/7/14 Roche Products ⭐ Case of the Week

AUTH/2725/7/14: Member of the public v Roche β€” Daily Mirror article about Avastin (No breach)

Anonymous complaint alleged Roche instigated a Daily Mirror story promoting off-label Avastin for brain tumours. Panel found allegations not proven on balance…

2014
CASE
AUTH/2710/4/14 Meda Pharmaceuticals

GP complaint upheld: Meda Dymista ad claim β€œdrug of choice” ruled misleading (AUTH/2710/4/14)

A GP challenged a Dymista ad claiming it β€œcan be considered the drug of choice” for allergic rhinitis. PMCPA ruled the claim…

2013
CASE
AUTH/2664/11/13 Takeda

Takeda: delayed clinical trial results disclosure for Daxas led to breaches (AUTH/2664/11/13)

A member of the public cited an ABPI-funded transparency study alleging missing trial results. PMCPA found no breach for Mepact/Edarbi (no UK…

2008
CASE
AUTH/2083/1/08 Roche Products

Roche breached Clause 9.9 after GP received unsolicited promotional email about Tamiflu via an agency (AUTH/2083/1/08)

A GP complained about an unsolicited promotional Tamiflu email sent to an NHS address via an agency. The Panel found no evidence…

2015
CASE
AUTH/2813/12/15 Pfizer

AUTH/2813/12/15: Anonymous (non-contactable) v Pfizer β€” exhibition stand hospitality at ESC Congress (No breach)

Anonymous HCP alleged Pfizer’s ESC 2015 congress stands were extravagant and created a party atmosphere, including flavoured iced drinks. Panel found hospitality…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training